The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?
Open accessAbstract
Folate receptor α (FRα) is a membrane‐bound protein with high affinity for binding and transporting physiologic levels of folate into cells. Folate is a basic component of cell metabolism and DNA synthesis and repair, and rapidly dividing cancer cells have an increased requirement for folate to maintain DNA synthesis, an observation supported by the widespread use of antifolates in cancer chemotherapy. FRα levels are high in specific malignant tumors of epithelial origin compared to normal cells, and are positively associated with tumor stage and grade, raising questions of its role in tumor etiology and progression. It has been suggested that FRα might confer a growth advantage to the tumor by modulating folate uptake from serum or by generating regulatory signals. Indeed, cell culture studies show that expression of the FRα gene, FOLR1, is regulated by extracellular folate depletion, increased homocysteine accumulation, steroid hormone concentrations, interaction with specific transcription factors and cytosolic proteins, and possibly genetic mutations. Whether FRα in tumors decreases in vivo among individuals who are folate sufficient, or whether the tumor's machinery sustains FRα levels to meet the increased folate demands of the tumor, has not been studied. Consequently, the significance of carrying a FRα‐positive tumor in the era of folic acid fortification and widespread vitamin supplement use in countries such as Canada and the United States is unknown. Epidemiologic and clinical studies using human tumor specimens are lacking and increasingly needed to understand the role of environmental and genetic influences on FOLR1 expression in tumor etiology and progression. This review summarizes the literature on the complex nature of FOLR1 gene regulation and expression, and suggests future research directions. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Modern Nutrition in Health and Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-508_7 · Cited by 3,379
Apoptosis in cancer therapy: Crossing the threshold
Fisher, D. E. (1994) · Cell · doi:10.1016/0092-8674(94)90518-5 · Cited by 1,315
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
Haensler, J., & Szoka, F. C. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00023a012 · Cited by 1,207
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B., & Ames, B. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3290 · Cited by 1,139
Folate and Carcinogenesis: An Integrated Scheme
Choi, S.-W., & Mason, J. B. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.129 · Cited by 944
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling
Le Roy, C., & Wrana, J. L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1571 · Cited by 871
Elnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649
Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J., & James, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002725200 · Cited by 640
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.
Leamon, C. P., & Low, P. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5572 · Cited by 554
Overexpression of folate binding protein in ovarian cancers
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f · Cited by 521
The glycosyl-phosphatidylinositol anchor of membrane proteins
Low, M. G. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(89)90014-2 · Cited by 517
Sequestration of GPI-Anchored Proteins in Caveolae Triggered by Cross-Linking
Mayor, S., Rothberg, K. G., & Maxfield, F. R. (1994) · Science · doi:10.1126/science.7516582 · Cited by 510
The biological chemistry of folate receptors
Antony, A. (1992) · Blood · doi:10.1182/blood.v79.11.2807.2807 · Cited by 495
Antony, A. C. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.002441 · Cited by 470
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Folate-binding protein is a marker for ovarian cancer.
Campbell, I., Jones, T. A., Foulkes, W. D., & Trowsdale, J. (1991) · PubMed · Cited by 457
Epidemiologic Studies of Folate and Colorectal Neoplasia: a Review
Giovannucci, E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2350s · Cited by 448
Rothberg, K. G., Ying, Y. S., Kolhouse, J. F., Kamen, B. A., & Anderson, R. G. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.637 · Cited by 441
Kelly, P., McPartlin, J., Goggins, M., Weir, D., & Scott, J. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.6.1790 · Cited by 393
Stern, L. L., Mason, J., Selhub, J., & Choi, S. (2000) · PubMed · Cited by 387
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Folate-mediated targeting: from diagnostics to drug and gene delivery
Leamon, C. P., & Low, P. S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01594-4 · Cited by 375
Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development
Piedrahita, J. A., Oetama, B., Bennett, G. D., van Waes, J., Kamen, B. A., Richardson, J., Lacey, S. W., Anderson, R. G. W., & Finnell, R. H. (1999) · Nature Genetics · doi:10.1038/13861 · Cited by 374
Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast Cancer
Zhang, S. M., Willett, W. C., Selhub, J., Hunter, D. J., Giovannucci, E. L., Holmes, M. D., Colditz, G. A., & Hankinson, S. E. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.373 · Cited by 354
Cholesterol-dependent retention of GPI-anchored proteins in endosomes
Mayor, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4626 · Cited by 309
Folate receptor-targeted drugs for cancer and inflammatory diseases
Low, P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.003 · Cited by 306
Coney, L. R., Tomassetti, A., Carayannopoulos, L. N., Frasca, V., Kamen, B. A., COLNAGHI, M. I., & Zurawski, V. R. (1991) · PubMed · Cited by 293
Kamen, B. A., Wang, M. T., Streckfuss, A. J., Peryea, X., & Anderson, R. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68284-5 · Cited by 287
Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome
Ramaekers, V. T., Rothenberg, S. P., Sequeira, J. M., Opladen, T., Blau, N., Quadros, E. V., & Selhub, J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043160 · Cited by 285
Righetti, S. C., Torre, G. D., Pilotti, S., Ménard, S., Ottone, F., Colnaghi, M. I., Pierotti, M. A., Lavarino, C. E., Cornarotti, M., Oriana, S., et al. (1996) · PubMed · Cited by 276
Folate receptor endocytosis and trafficking
Sabharanjak, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.010 · Cited by 273
Kamen, B. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.002 · Cited by 264
Ramaekers, V. T., & Blau, N. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204001471 · Cited by 245
Rothenberg, S. P., da Costa, M. P., Sequeira, J. M., Cracco, J., Roberts, J. L., Weedon, J., & Quadros, E. V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031145 · Cited by 241
Ross, J. F., Wang, H., Behm, F. G., Mathew, P., Wu, M., Booth, R., & Ratnam, M. (1999) · Cancer · Cited by 225
Henderson, G. B. (1990) · Annual Review of Nutrition · doi:10.1146/annurev.nu.10.070190.001535 · Cited by 214
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical
Leamon, C. P., Parker, M. A., Vlahov, I. R., Xu, L.-C., Reddy, J. A., Vetzel, M., & Douglas, N. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0200430 · Cited by 210
Wu, M., Gunning, W. T., & Ratnam, M. (1999) · PubMed · Cited by 210
Strathdee, G., Appleton, K., Illand, M., Millan, D. W. M., Sargent, J., Paul, J., & Brown, R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64059-x · Cited by 205
Endocytosis of GPI-linked membrane folate receptor-alpha.
Rijnboutt, S., Jansen, G., Posthuma, G., Hynes, J. B., Schornagel, J. H., & Strous, G. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.35 · Cited by 192
Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study.
Shrubsole, M. J., Jin, F., Dai, Q., Shu, X.-O., Potter, J. D., Hébert, J. R., Gao, Y. T., & Zheng, W. (2001) · PubMed · Cited by 185
Antony, A. C., Kane, M. A., Portillo, R. M., Elwood, P. C., & Kolhouse, J. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95679-6 · Cited by 174
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
Lu, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00215-3 · Cited by 172
Shen, F., Wu, M., Ross, J. F., Miller, D., & Ratnam, M. (1995) · Biochemistry · doi:10.1021/bi00016a042 · Cited by 168
Xin, W., Feng, S., Freisheim, J. H., Gentry, L. E., & Ratnam, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90089-2 · Cited by 167
Leamon, C. P., Pastan, I., & Low, P. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74542-6 · Cited by 166
Tasker, P. W. G. (1960) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(60)90034-1 · Cited by 165
Toffoli, G., Russo, A. G., Gallo, A., Cernigoi, C., Miotti, S., Sorio, R., & Boiocchi, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<121::aid-ijc4>3.0.co;2-v · Cited by 164
Impact of Extracellular Folate Levels on Global Gene Expression
Jhaveri, M. S., Wagner, C., & Trepel, J. B. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1288 · Cited by 161
Zhao, X. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.005 · Cited by 153
Chatterjee, S., Smith, E. R., Hanada, K., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1583 · Cited by 151
Cytotoxicity of momordin-folate conjugates in cultured human cells.
Leamon, C. P., & Low, P. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73992-1 · Cited by 142
Shaw, G. M., Lammer, E. J., Zhu, H., Baker, M. W., Neri, E., & Finnell, R. H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10195 · Cited by 139
Folic acid — vitamin and panacea or genetic time bomb?
Lucock, M. D., & Yates, Z. R. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1558 · Cited by 132
Brigle, K. E., Spinella, M. J., Sierra, E. E., & Goldman, I. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22974 · Cited by 125
Spinella, M. J., Brigle, K. E., Sierra, E. E., & Goldman, I. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.7842 · Cited by 124
Folate-receptor-targeted radionuclide imaging agents
Ke, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.004 · Cited by 123
The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.
Kamen, B. A., Smith, A. K., & Anderson, R. G. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115150 · Cited by 120
Mantovani, L., Miotti, S., Ménard, S., Canevari, S., Raspagliesi, F., Bottini, C., Bottero, F., & Colnaghi, M. I. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90257-7 · Cited by 120
Development of a Tumor-Targeting MR Contrast Agent Using the High-Affinity Folate Receptor
Konda, S. D., Aref, M., Brechbiel, M. W., & Wiener, E. C. (2000) · Investigative Radiology · doi:10.1097/00004424-200001000-00006 · Cited by 119
Glycosyl-phosphatidylinositol-anchored membrane proteins.
Brown, D., & Waneck, G. L. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34895 · Cited by 111
Feigelson, H. S., Jonas, C. R., Robertson, A. S., McCullough, M. L., Thun, M. J., & Calle, E. E. (2003) · PubMed · Cited by 109
Are dietary factors involved in DNA methylation associated with colon cancer?
Slattery, M. L., Schaffer, D., Edwards, S. L., Ma, K., & Potter, J. D. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514553 · Cited by 106
Ward, C. M., Pechar, M., Oupický, D., Ulbrich, K., & Seymour, L. W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.296 · Cited by 100
Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate.
Matsue, H., Rothberg, K. G., Takashima, A., Kamen, B. A., Anderson, R. G. W., & Lacey, S. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6006 · Cited by 99
Kelley, K. M. M., Rowan, B. G., & Ratnam, M. (2003) · PubMed · Cited by 97
Trembath, D. G., Sherbondy, A. L., Vandyke, D. C., Shaw, G. M., Todoroff, K., Lammer, E. J., Finnell, R. H., Marker, S., Lerner, G. R., & Murray, J. C. (1999) · Teratology · doi:10.1002/(sici)1096-9926(199905)59:5<331::aid-tera4>3.0.co;2-l · Cited by 97
Antifolates targeted specifically to the folate receptor
Jackman, A. L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.003 · Cited by 97
Shaw, G. M. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg189 · Cited by 86
Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake.
Ritter, T. E., Fajardo, O., Matsue, H., Anderson, R. G. W., & Lacey, S. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3824 · Cited by 83
Antony, A. C., Utley, C. S., Marcell, P. D., & Kolhouse, J. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33987-5 · Cited by 80
Miotti, S., Bagnoli, M., Tomassetti, A., COLNAGHI, M. I., & Canevari, S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.349 · Cited by 76
Differential expression of folate receptor in pituitary adenomas.
Evans, C.-O., Reddy, P., Brat, D. J., O’Neill, E. B., Craige, B., Stevens, V. L., & Oyesiku, N. M. (2003) · PubMed · Cited by 74
Antony, A. C., Tang, Y.-S., Khan, R. A., Biju, M. P., Xiao, X., Li, Q.-J., Sun, X.-L., Jayaram, H. N., & Stabler, S. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci11548 · Cited by 74
Lack of association between mutations in the folate receptor-alpha gene and spina bifida.
Barber, R. C., Shaw, G. M., Lammer, E. J., Greer, K. A., Biela, T. A., Lacey, S. W., Wasserman, C. R., & Finnell, R. H. (1998) · PubMed · Cited by 73
Pillai, M. R., Chacko, P., Kesari, L. A., Jayaprakash, P. G., Jayaram, H. N., & Antony, A. C. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.8.569 · Cited by 71
The Role of α-Folate Receptor-Mediated Transport in the Antitumor Activity of Antifolate Drugs
Theti, D. S., & Jackman, A. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0157 · Cited by 70
Tran, T., Shatnawi, A. A., Zheng, X., Kelley, K. M. M., & Ratnam, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2890 · Cited by 67
Lack of association between mutations in the folate receptor-? gene and spina bifida
Barber, R. C., Shaw, G. M., Lammer, E. J., Greer, K. A., Biela, T. A., Lacey, S. W., Wasserman, C. R., & Finnell, R. H. (1998) · American Journal of Medical Genetics · Cited by 63
Saikawa, Y., Price, K., Hance, K. W., Chen, T. Y., & Elwood, P. C. (1995) · Biochemistry · doi:10.1021/bi00031a018 · Cited by 61
Sadasivan, E., Cedeno, M., & Rothenberg, S. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37605-6 · Cited by 58
Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium
Chung-Tsen, H., & Dolnick, B. J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90235-o · Cited by 52
A Step Further in Understanding the Biology of the Folate Receptor in Ovarian Carcinoma
Bagnoli, M., Canevari, S., Figini, M., Mezzanzanica, D., Raspagliesi, F., Tomassetti, A., & Miotti, S. (2003) · Gynecologic Oncology · doi:10.1006/gyno.2002.6705 · Cited by 48
Sun, X.-L., & Antony, A. C. (1996) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78324-0 · Cited by 42
Sun, X., Murphy, B. R., Li, Q. J., Gullapalli, S., Mackins, J. Y., Jayaram, H. N., Srivastava, A., & Antony, A. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118192 · Cited by 35
Tomassetti, A., Mangiarotti, F., Mazzi, M., Sforzini, S., Miotti, S., Galmozzi, E., Elwood, P. C., & Canevari, S. (2003) · PubMed · Cited by 31
Hsueh, C.-T., & Dolnick, B. J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90413-8 · Cited by 28
ROBERTS, S. J., Chung, K.-N., Nachmanoff, K., & Elwood, P. C. (1997) · Biochemical Journal · doi:10.1042/bj3260439 · Cited by 26
Sadasivan, E., Regec, A. L., & Rothenberg, S. P. (2002) · Gene · doi:10.1016/s0378-1119(02)00591-7 · Cited by 25
Bolton, J., Wood, S. A., Kennedy, D. D., Don, R. H., & Mattick, J. S. (1999) · Gene · doi:10.1016/s0378-1119(99)00081-5 · Cited by 22
Characterization of a High-Affinity Folate Receptor in Normal and Malignant Human Testicular Tissue
Holm, J., Hansen, S. I., Høier‐Madsen, M., Christensen, T. B., & Nichols, C. W. (1999) · Bioscience Reports · doi:10.1023/a:1020219029206 · Cited by 16
Nilsson, T., & Börjel, A. K. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.013 · Cited by 9
Cited by
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Foroozandeh, P., & Aziz, A. A. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2728-6 · Cited by 1,377
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
Structural basis for molecular recognition of folic acid by folate receptors
Chen, C., Ke, J., Zhou, X. E., Yi, W., Brunzelle, J. S., Li, J., Yong, E.-L., Xu, H. E., & Melcher, K. (2013) · Nature · doi:10.1038/nature12327 · Cited by 694
Exploiting the folate receptor α in oncology
Scaranti, M., Cojocaru, E., Banerjee, S., & Banerji, U. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0339-5 · Cited by 593
Metadata
- Authors
- Kelemen, L. E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-04-27
- Volume
- 119
- Issue
- 2
- Pages
- 243-250
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1963776452
- Cited by
- 509
- References
- 96
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.